Renyi Xie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Renyi Xie has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Cheng Li
Eye Institute & Affiliated Xiamen Eye Center, School of Medicine, Xiamen University, Xiamen 361102, China
1 shared publication Heming Wu
Department of Basic Medical Sciences, School of Medicine, Xiamen University, Xiamen, China
1 shared publicationJianbo Jin
Eye Institute and Affiliated Xiamen Eye Center, School of Medicine, Xiamen University, Xiamen, Fujian, China
1 shared publicationJingxun Guo
Eye Institute and Affiliated Xiamen Eye Center, School of Medicine, Xiamen University, Xiamen, Fujian, China
1 shared publicationKai Fan
Eye Institute and Affiliated Xiamen Eye Center, School of Medicine, Xiamen University, Xiamen, Fujian, China
1 shared publicationLan Zheng
Eye Institute and Affiliated Xiamen Eye Center, School of Medicine, Xiamen University, Xiamen, Fujian, China
1 shared publication
Latest Publications
- Open Access
- 23 February 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1782101
Case Report: From imaging to genetics: a case of congenital restrictive strabismus with SEOM expands the 22q11.2 duplication syndrome phenotype
This study presents a case of restrictive strabismus with ipsilateral enophthalmos secondary to a supernumerary extraocular muscle (SEOM). Orbital MRI and posterior segment OCT provided direct imaging evidence that delineated the posterior origin of the SEOM and its mechanical traction on the globe, while also revealing concomitant hypoplasia of the medial and lateral rectus muscles. These findings together elucidate the mechanical basis of both ocular motility restriction and enophthalmos in this case. Genetic analysis revealed a pathogenic duplication in the 22q11.21 region, which—to our knowledge—is the first reported association linking this variant to SEOM-related restrictive strabismus, thereby expanding the ocular phenotypic spectrum of the 22q11.2 duplication syndrome. The discussion underscores that surgical intervention carries substantial risk due to the deep, optic-nerve-adjacent location of the SEOM and the presence of rectus muscle hypoplasia, compounded by the reportedly poorer prognosis associated with posterior SEOM (Type 3). Hence, conservative management was advised. This case highlights the central diagnostic role of MRI and offers novel insights into the etiology and individualized management of anomalous orbital structures.
- 23 February 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1782101
Open AccessCase Report: From imaging to genetics: a case of congenital restrictive strabismus with SEOM expands the 22q11.2 duplication syndrome phenotype
This study presents a case of restrictive strabismus with ipsilateral enophthalmos secondary to a supernumerary extraocular muscle (SEOM). Orbital MRI and posterior segment OCT provided direct imaging evidence that delineated the posterior origin of the SEOM and its mechanical traction on the globe, while also revealing concomitant hypoplasia of the medial and lateral rectus muscles. These findings together elucidate the mechanical basis of both ocular motility restriction and enophthalmos in this case. Genetic analysis revealed a pathogenic duplication in the 22q11.21 region, which—to our knowledge—is the first reported association linking this variant to SEOM-related restrictive strabismus, thereby expanding the ocular phenotypic spectrum of the 22q11.2 duplication syndrome. The discussion underscores that surgical intervention carries substantial risk due to the deep, optic-nerve-adjacent location of the SEOM and the presence of rectus muscle hypoplasia, compounded by the reportedly poorer prognosis associated with posterior SEOM (Type 3). Hence, conservative management was advised. This case highlights the central diagnostic role of MRI and offers novel insights into the etiology and individualized management of anomalous orbital structures.
- Top Cited PapersOpen Access
- 15 January 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 11, 1501175
Global, regional, and national burden inequality of chronic kidney disease, 1990–2021: a systematic analysis for the global burden of disease study 2021
Background: Chronic kidney disease (CKD) is a significant global health issue, often linked to diabetes, hypertension, and glomerulonephritis. However, aggregated statistics can obscure heterogeneity across subtypes, age, gender, and regions. This study aimed to analyze global CKD trends from 1990 to 2021, focusing on age, gender, socio-demographic index (SDI), and regional variations.Methods: Data were extracted from the Global Burden of Disease (GBD) 2021 database, covering prevalence, incidence, mortality, and disability-adjusted life years (DALYs). These were presented as counts per 100,000 population and age-standardized rates, with uncertainty intervals (UIs) to highlight variability. Joinpoint regression was used to assess trends over the 30-year period.Results: In 2021, global CKD prevalence was 359 million, with 11.13 million new cases, 1.53 million deaths, and 44.45 million DALYs—up 92, 156, 176, and 114% since 1990. While prevalence slightly declined, incidence, mortality, and DALYs increased significantly. CKD burden varied by region and age, with notable gender disparities.Conclusion: The study highlights a dramatic rise in CKD burden linked to population growth and aging, emphasizing the need for targeted treatment and effective global healthcare policies.
- 15 January 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 11, 1501175
Top Cited PapersOpen AccessGlobal, regional, and national burden inequality of chronic kidney disease, 1990–2021: a systematic analysis for the global burden of disease study 2021
Background: Chronic kidney disease (CKD) is a significant global health issue, often linked to diabetes, hypertension, and glomerulonephritis. However, aggregated statistics can obscure heterogeneity across subtypes, age, gender, and regions. This study aimed to analyze global CKD trends from 1990 to 2021, focusing on age, gender, socio-demographic index (SDI), and regional variations.Methods: Data were extracted from the Global Burden of Disease (GBD) 2021 database, covering prevalence, incidence, mortality, and disability-adjusted life years (DALYs). These were presented as counts per 100,000 population and age-standardized rates, with uncertainty intervals (UIs) to highlight variability. Joinpoint regression was used to assess trends over the 30-year period.Results: In 2021, global CKD prevalence was 359 million, with 11.13 million new cases, 1.53 million deaths, and 44.45 million DALYs—up 92, 156, 176, and 114% since 1990. While prevalence slightly declined, incidence, mortality, and DALYs increased significantly. CKD burden varied by region and age, with notable gender disparities.Conclusion: The study highlights a dramatic rise in CKD burden linked to population growth and aging, emphasizing the need for targeted treatment and effective global healthcare policies.